Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Equity Capital Markets

<ul>
<li>Bio FD&amp;C is getting ready to complete its IPO in the Korean stock market in February 2022. </li>
<li>Founded in 2005, Bio FD&amp;C is a company that develops anti-aging materials with plant cell line design and plant cell culture technology.</li>
<li>
<strong>Currently, Bio FD&amp;C has</strong><strong>a gray market price of 90,000 won, which is 210% higher than the high end of the IPO price range.</strong>
</li>
</ul>


Bio FD&amp;C is getting ready to complete its IPO in the Korean stock market in February 2022. 
Founded in 2005, Bio FD&amp;C is a company that develops anti-aging materials with plant cell line design and plant cell culture technology.

Currently, Bio FD&amp;C hasa gray market price of 90,000 won, which is 210% higher than the high end of the IPO price range.



South Korea

Bio FD&C Co Ltd researches and develops plant cell technology. The Company develops plant derived recombinant growth factors, phytopeptides, rose cell lines and other plant cell culture technologies. Bio FD&C also produces stem cell promotor, urination improver, incontinence treatment health supplement and anti-aging materials.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bio FD&C (251120 KS)

Bio FD&C IPO Preview

Bio FD&C develops anti-aging materials with plant cell line design and plant cell culture technology. Bio FD&C has a gray market price of 90,000...

Douglas Kim

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)